Navigation Links
NxStage Announces Third Quarter 2011 Investor Conference Schedule
Date:8/5/2011

LAWRENCE, Mass., Aug 5, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference.  

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)Lazard Capital Markets 2nd Annual Medical Technology Corporate Access DayPeninsula Hotel, Chicago, ILTuesday, Aug. 9, 20112011 Canaccord Genuity Growth Conference
Intercontinental Boston, Boston MAWednesday, Aug. 10, 2011
9:00 a.m. ETRodman & Renshaw Annual Global Investment ConferenceThe Waldorf-Astoria, New York, NYSeptember 11-13, 2011Jefferies 2011 Global Healthcare ConferenceThe Waldorf Hilton, London, UKSeptember 27-28, 2011About NxStage MedicalNxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking StatementsThis release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Brown's plans to present at these conferences.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com


'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Report Third Quarter 2009 Financial Results
4. NxStage(R) Reports Significant Interim FREEDOM Study Results
5. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
6. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
7. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
8. NxStage(R) Secures $15 Million Revolving Line of Credit
9. NxStage to Report Third Quarter Fiscal 2010 Financial Results
10. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
11. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... -- A highly innovative, personalized cell-based treatment for a high-risk form of ... oncologists from Children,s Hospital of Philadelphia today reported ... leukemia (ALL). The physician-scientists presented findings at the annual meeting ... . Continue Reading ... ...
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories, un ... la Compañía, el INSTI HIV Self Test , a los miembros de ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... DUBLIN , Dec 2, 2016 Research ... Market Size, Share, Development, Growth and Demand Forecast to 2022" report ... , , ... revenue of $6 billion in 2015, and it is expected to grow ... ultrasound segment is expected to witness faster growth during the forecast period, ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 04, 2016 , ... Patients ... can now take advantage of a cosmetic procedure known as Carbon Dioxide ... reduces the appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
(Date:12/2/2016)... AL (PRWEB) , ... December 02, 2016 , ... ... from across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF ... Schmitz, will help provide scholarship funds for area students and operating support to ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, ... Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to a ... changes during this period order for their new policy to go into effect in ...
(Date:12/2/2016)... ... 02, 2016 , ... Dr. Raffi Hovsepian, a leading plastic, ... 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The prestigious ... experience, and professional associations. , One the most frequently honored surgeons in ...
Breaking Medicine News(10 mins):